Abstract
Vitamin D is recognized to serve a wide range of biological functions. The presence of vitamin D receptors on different tissues explains it’s diversity of actions. Reduced levels of vitamin D is associated with insulin resistance and increased diabetes risk. The study included 50 normal healthy individuals and 49 type 2 diabetes subjects. Fasting blood glucose, total cholesterol, triglycerides, HDLc, fasting insulin, parathyroid hormone, calcium, albumin and Homeostasis model for assessment of insulin resistance (HOMAIR) were measured in all the study participants. Type 2 diabetes subjects were divided into group 1 with 25 hydroxy vitamin D (25(OH)D) ≤20 ng/ml and group 2 with 25(OH)D >20 ng/ml. By the results of this study, the mean 25(OH)D level was low (20.09 ng/ml) in type 2 diabetes compared to controls (23.89 ng/ml) and the p value was 0.02. The estimated insulin resistance by HOMAIR was more in group 1 than in group 2 of diabetes with p value of 0.037. The Pearson’s correlation-coefficient was negative for 25(OH)D and insulin in type 2 diabetes (r = −0.294), 25(OH)D was negatively correlated with HOMAIR in total subjects. Type 2 diabetes subjects had reduced levels of vitamin D than normal individuals. The insulin resistance was more in vitamin D deficiency state. Hence vitamin D has a role in glucose metabolism, deficiency can result in insulin resistance and diabetes.
Similar content being viewed by others
References
Kochhupalli N. The physiology of vitamin D. Indian J Med Res. 2008;127:256–62.
Nagapal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev. 2005;26:662–7.
Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr. 2003;89(5):55–72.
Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–81.
Takiishi T, Gysemans C, Bouillon R, Mathieu C. Vitamin D and diabetes. Rheum Dis Clin North Am. 2012;38(1):179–206.
Paul K, Maarit L, Catharina M, Tommi H, Jukka M, H Markku, et al. Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology. 2008;19(5):666–71.
Pittas AG, Sun Q, Manson JE, Dawson-Hughes B, Hu FB. Plasma 25-hydroxy vitamin D concentration and risk of incident type 2 diabetes in women. Diabetes Care. 2010;33:2021–3.
Ramachandran A, Snehalatha C. Current scenario of diabetes in India. J Diabetes. 2009;1(1):18–28.
Mohan V, Sandeep S, Deepa R, Shah B, Vrghese C. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res. 2007;125:217–30.
Hodgkin P, Hine PM, Kay GH, Lumb GA, Stanbury SW. Vitamin D deficiency in Asians at home and in Britain. Lancet. 1973;302:167–72.
Harinarayan CV, Gupta N, Kochupillai N. Vitamin D status in primary hyperparathyroidism in India. Clin Endocrinol. 1995;43:351–8.
Goswami R, Gupta N, Goswami D, Marwaha RK, Tandon N, Kochupillai N. Prevalence and significance of low 25-hydroxy vitamin D concentration in healthy subjects in Delhi. Am J Clin Nutr. 2000;72:472–5.
Harinarayan CV, Ramalakshmi T, Prasad UV, Sudhakar D, Srinivasarao PVLN, Sarma KVS, et al. High prevalence of low dietary calcium, high phytate consumption, and vitamin D deficiency in healthy south Indians. Am J Clin Nutr. 2007;85:1062–7.
Harinarayan CV. Prevalence of vitamin D insufficiency in postmenopausal south Indian women. Osteoporos Int. 2005;16:397–402.
Harinarayan CV, Ramalakshmi T, Prasad UV, Sudhakar D. Vitamin D status in Andhra Pradesh: a population based study. Indian J Med Res. 2008;127:211–8.
Harinarayan CV, Ramalakshmi T, Venkata Prasad U. High prevalence of low dietary calcium and low vitamin D status in healthy South Indians. Asia Pac J Clin Nutr. 2004;13:359–64.
Chiu KC, Chu A, Go VLW, Saad MF. Hypovitaminosis D is associated with insulin resistance and β cell dysfunction. Am J Clin Nutr. 2004;79:820–5.
Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. a systematic review and meta-analysis. J Clin Endocrinol Metab. 2007;92:2017–29.
scragg R, Sowers M, Bell C. Serum 25-hydroxy vitamin D, diabetes and ethnicity in the third national health and nutrition examination survey. Diabetes Care. 2004;27:2813–8.
Ford ES, Ajani UA, McGuire LC, Liu S. Concentration of serum vitamin D and the metabolic syndrome among US adults. Diabetes Care. 2005;28:1228–30.
Bourlon PM, Billaudel B. Dussert. Influence of Vitami D3 deficiency and 1,25 dihydroxy D3 on denovo insulin biosynthesis in islets of the rat endocrine pancreas. J Endocrinol. 1999;160:87–95.
Danescu LG, Levy S, Levy J. Vitamin D and diabetes mellitus. Endocrine. 2009;35:11–7.
Giulietti A, Van Etten E, Overbergh L, Stoffels K, Bouillon R, Mathieu C. Monocytes from type 2 diabetic patients have a pro-inflammatory profile: 1,25-dihydroxy vitamin D3 works as anti inflammatory. Diabetes Res Clin Pract. 2007;77(1):47–57.
Cohen-Lahav M, Douvdevani A, Chaimovitz C, Shany S. The anti inflammatory activity of 1,25 dihydroxy vitamin D3 in macrophages. J Steroid Biochem Mol Biol. 2007;103:558–62.
Saxe AW, Gibson G, Gingerich RL, Levy J. Parathyroid hormone decreases in vivo insulin effect on glucose utilization. Calcif Tissue Int. 1995;57:127–32.
Teegarden D, Donkin SS. Vitamin D: emerging new roles in insulin sensitivity. Nutr Res Rev. 2009;22:82–92.
Ling L, Zhijie Y, Pan A, Hu FB, Franco OH, Li H, et al. Plasma 25-hydroxy vitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care. 2009;32:1278–83.
Bonora E, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, et al. HOMA estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetes subjects. Diabetes Care. 2002;25(7):135–41.
Harinarayan CV, Joshi SR. Vitamin D status in India—its implications and remedial measures. J Assoc Physicians India. 2009;57:40–8.
Gagnon C, Lu ZX, Magliano DJ, Dunstan DW, Shaw JE, Zimmet PZ, et al. Serum 25-hydroxy vitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian diabetes, obesity and lifestyle study). Diabetes Care. 2011;34:1133–8.
Bischoff HA, Borchers M, Gudat F, Duermueller U, Theiler R, et al. In situ detection of 1, 25 dihydroxy vitamin D receptor in human skeletal muscle tissue. Histochem J. 2001;33(1):19–24.
Alvarez JA, Ashraf A. Role of Vitamin D in Insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol. 2010;2010:1–18.
Norman AW. Vitamin D receptor: new assignments for an already busy receptor. Endocrinology. 2006;147:5542–8.
Li J, Byrne ME, Chang E, Jiang Y, Donkin SS, Buhman KK, et al. 1α,25 Dihydroxy vitamin D hydroxylase in adipocytes. J Steroid Biochem Mol Biol. 2008;112:122–6.
Ogunkolade BW, Boucher BJ, Prahl JM. Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes. 2002;51:2294–300.
Calle C, Maestro B. Garcia–arencibia M. Genomic actions of 1,25-dihydroxy vitamin D3 on insulin receptor gene expression, insulin receptor number and insulin activity in kidney, liver and functions: VDRs, gene expression, and insulin secretion. Endocrinology. 1994;134:1602–10.
Nita G, Luan J, Cooper A, Boucher BJ, Wareham NJ. Baseline 25 hydroxy vitamin D is predictive of future glycemic status and Insulin resistance. The medical research council Ely prospective study—1990–2000. Diabetes. 2008;57(10):2619–25.
Pinelli NR, Jaber LA, Brown MB, Herman WH. Serum 25-hydroxy vitamin D and Insulin resistance, metabolic syndrome, and glucose intolerance among Arab Americans. Diabetes Care. 2010;33:1373–5.
Rathi N, Rathi A. Vitamin D and child health in the 21st century. Indian Pediatr. 2011;48:619–25.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bachali, S., Dasu, K., Ramalingam, K. et al. Vitamin D Deficiency and Insulin Resistance in Normal and Type 2 Diabetes Subjects. Ind J Clin Biochem 28, 74–78 (2013). https://doi.org/10.1007/s12291-012-0239-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-012-0239-2